Call Number (LC) Title Results
RC271.C3 D78 1996 Drug resistance / 1
RC271.C35 Camptothecin and camptothecin producing plants botany, chemistry, anticancer activity and biotechnology / 1
RC271.C35 C345 2005 Camptothecins in cancer therapy 1
RC271.C35 C35 1995 Camptothecins : new anticancer agents / 1
RC271.C44 Stem cell therapeutics for cancer /
Molecular therapy oncolytics 		3
RC271.C44 C45 1996 Cell therapy : stem cell transplantation, gene therapy, and cellular immunotherapy / 1
RC271.C44G796 Therapy with cultured cells / 1
RC271.C48 C46 1999 Chemokines and cancer / 1
RC271 .C5 Physiopathogenesis of Hematological Cancer.
A Practical Guide to Designing Phase II Trials in Oncology. 		2
RC271.C5 Cancer drug resistance : overviews and methods /
Drug resistance in cancer mechanisms and strategies /
Biosimilars for cancer treatment : a promising approach /
Nano drug delivery for cancer therapy principles and practices /
Medicines for cancer : mechanism of action and clinical pharmacology of chemo, hormonal, targeted, and immunotherapies /
Side effects of medical cancer therapy prevention and treatment /
The golden guide to oncologic pharmacy /
Logik Wiener Logikkolleg 1894/95 /
Resistance to immunotherapeutic antibodies in cancer : strategies to overcome resistance /
Polyphenols-based nanotherapeutics for cancer management /
Drug repurposing in cancer therapy : approaches and applications /
Inflammation, oxidative stress, and cancer : dietary approaches for cancer prevention /
Phase I Oncology Drug Development
Fast facts.
Management of chemotherapy-induced nausea and vomiting : new agents and new uses of current agents /
Quantum chemistry methods for oncological drugs
Drug resistance in colorectal cancer molecular mechanisms and therapeutic /
Statistical approaches in oncology clinical development /
Logik Wiener Logikkolleg 1894/95
Razoxane and dexrazoxane - two multifunctional agents experimental and clinical results /
Ph-interfering agents as chemosensitizers in cancer therapy
Nanotechnology applications for cancer chemotherapy
Nanoparticle drug delivery systems for cancer treatment
Molecular medicines for cancer : concepts and applications of nanotechnology /
Epigenetic regulation in overcoming chemoresistance
Caspases as molecular targets for cancer therapy /
Hybrid nanostructures in cancer therapy /
Microspheres and regional cancer therapy /
PROTAC-mediated protein degradation : a paradigm shift in cancer therapeutics /
Biological mechanisms and the advancing approaches to overcoming cancer drug resistance /
A practical guide to designing phase II trials in oncology /
Cancer targeted drug delivery : an elusive dream /
Lippincott's Cancer Chemotherapy Handbook.
Handbook of cancer treatment-related toxicities /
Pharmaceutical aspects of cancer chemotherapy /
Cancer and chemotherapy /
Prevention of nausea and vomiting in cancer patients /
Novel designs of early phase trials for cancer therapeutics /
Resistance to anti-cancer therapeutics targeting receptor tyrosine kinases and downstream pathways /
Cancer and chemotherapy.
Cancer chemotherapy /
Skeel's handbook of cancer therapy /
Elemene antitumor drugs : molecular compatibility theory and its applications in new drug development and clinical practice /
Anti-angiogenesis strategies in cancer therapeutics
Handbook of targeted cancer therapy /
Epigenetic regulation of cancer in response to chemotherapy
Principles of cancer treatment and anticancer drug development /
FASTtrack Pharmaceutics - Dosage Form and Design
Rethinking platinum anticancer drug design : towards targeted and immuno-chemotherapeutic approaches /
Drug efflux pumps in cancer resistance pathways from molecular recognition and characterization to possible inhibition strategies in chemotherapy /
Medicinal chemistry of anticancer drugs
Infections in cancer chemotherapy a symposium held at the Institute Jules Bordet, Brussels, Belgium ; chairman, J. Klastersky.
Prognostic and therapeutic applications of RKIP in cancer
Cancer II /
Computational methods in drug discovery and repurposing for cancer therapy /
Medicinal chemistry of anticancer drugs /
Skin care in radiation oncology a practical guide / 		57
RC271.C5 A28 2005eb Advances in targeted cancer therapy 1
RC271.C5 A35 2009eb Cancer chemotherapy / 1
RC271.C5 A38 1987 Advances in cancer chemotherapy : lymphomas and breast cancer : proceedings of a symposium held December 5, 1986, in San Francisco / 1
RC271.C5 A38 2013eb Advances in cancer drug targets. 1
RC271.C5 A5 1953 Antimetabolites and cancer : a symposium presented on December 28-29, 1953, at the Boston meeting of the American Association for the Advancement of Science / 1
RC271.C5 A66 1984 Anticancer and interferon agents : synthesis and properties / 1
RC271.C5 A67 Anticancer agents based on natural product models / 2
RC271.C5 A67245 1999eb Anticancer drug toxicity : prevention, management, and clinical pharmacokinetics / 1
RC271.C5 A6725 1994 Anticancer drugs : antimetabolite metabolism and natural anticancer agents / 1
RC271.C5 A6726 1994 Anticancer drugs : reactive metabolism and drug interactions / 1